openPR Logo
Press release

Ankylosing Spondylitis Treatment Market Estimated to Reach Revenues by 2021

07-17-2017 03:17 PM CET | Health & Medicine

Press release from: Persistence Market Research

Ankylosing Spondylitis Treatment Market Estimated to Reach

The exact cause of ankylosing spondylitis is still unknown; however, a genetic link has been observed in some cases. People suffering from ankylosing spondylitis carry a gene called HLA-B27. Ankylosing spondylitis can be diagnosed via X-rays of the back and pelvis; or by physical examination. Currently, a cure for ankylosing spondylitis is not available on the market; the available treatments mainly help reduce the discomfort caused by ankylosing spondylitis. Various treatment options include: hysical and occupational therapy, exercises, medications and surgery.

Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years.

Get access to full summary @: http://www.persistencemarketresearch.com/market-research/ankylosing-spondilitis-treatment-market.asp

Various medications available for ankylosing spondylitis treatment are: Disease-modifying anitrheumatic drugs (DMARDs), such as methotrexate; nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin; and biologics, such as enbrel, humira, cimzia and remicade.

The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.

North America dominates the global market for ankylosing spondylitis treatment due to the high prevalence of the disease and increased adoption of ankylosing spondylitis treatment options in the region. In addition, technological advancements are driving ankylosing spondylitis treatment in North America. Asia, followed by Europe, is expected to experience high growth rate in the ankylosing spondylitis treatment market over the next few years. China and India are expected to be the fastest-growing ankylosing spondylitis treatment markets in the Asian region. Some of the key driving forces for ankylosing spondylitis treatment market in emerging countries are a large pool of patients and rising government initiatives in the form of funding.

The increasing prevalence of ankylosing spondylitis itself is a major factor impelling the global ankylosing spondylitis treatment market. In addition, factors such as rising awareness, technological advancements, government initiatives and improvement in the reimbursement scenario augur well for the global ankylosing spondylitis treatment market. However, factors such as high treatment costs and a dearth of experienced professionals are restraining the global ankylosing spondylitis treatment market. In addition, a low adoption rate of ankylosing spondylitis treatment options is restraining the market.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4766

Growing population and economies in the developing countries such as India and China are expected to offer lucrative opportunities for the global ankylosing spondylitis treatment market. Innovation of new, more efficient products is expected to offer growth opportunities for the global ankylosing spondylitis treatment market. A rising number of mergers and acquisitions, new product launches, and more collaborations and partnerships are some of the latest trends that have been observed in the global ankylosing spondylitis treatment market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis Treatment Market Estimated to Reach Revenues by 2021 here

News-ID: 627377 • Views:

More Releases from Persistence Market Research

Automotive Parts Aftermarket Outlook 2023-2033: Key Players Like Bosch, Denso, Magna, Continental, and ZF Leading Market Growth
Automotive Parts Aftermarket Outlook 2023-2033: Key Players Like Bosch, Denso, M …
The Automotive Parts Aftermarket has become a critical component of the global automotive ecosystem. According to Persistence Market Research, the market size reached US$ 548.5 billion in 2022 and is projected to expand to US$ 576.5 billion in 2023. With the replacement parts segment expected to achieve a total value of US$ 984.7 billion by 2033, the market is set to grow at a CAGR of 5.5% from 2023 to
Centrifugal Pumps Market Set to Reach US$ 55.7 Billion by 2032, Insights from Persistence Market Research
Centrifugal Pumps Market Set to Reach US$ 55.7 Billion by 2032, Insights from Pe …
The global centrifugal pumps market is poised for significant expansion, with the market projected to grow from US$ 41.2 billion in 2025 to reach US$ 55.7 billion by 2032, reflecting a CAGR of 4.4%. The growth is primarily fueled by increasing demand for efficient water management solutions across agriculture, industrial manufacturing, and municipal services. Centrifugal pumps play a crucial role in ensuring seamless fluid transfer, reducing energy consumption, and maintaining
CAR T-cell Therapy Market to Touch US$24 Billion by 2032, Reports Persistence Market Research
CAR T-cell Therapy Market to Touch US$24 Billion by 2032, Reports Persistence Ma …
The global CAR T-cell therapy market is experiencing transformative growth, projected to expand from an estimated US$5.8 billion in 2025 to US$24 billion by 2032, reflecting a compound annual growth rate (CAGR) of 25% during the forecast period from 2025 to 2032. This growth trajectory is being driven by a confluence of factors, including rising cancer prevalence, especially hematologic malignancies, and continuous advancements in gene-editing technologies and immunotherapy. As these
Hydraulic Fluid Connector Market Technological Innovations, Efficiency Drivers, and Emerging Opportunities Shaping Fluid Power Systems
Hydraulic Fluid Connector Market Technological Innovations, Efficiency Drivers, …
Hydraulic fluid connectors are used only in fluid power and piping systems for efficient operation in industrial fluid networks. A hydraulic fluid connector is deployed in these systems to increase the total machine performance irrespective of applications. Hydraulic fluid connectors are used to enhance uptime in the remote applications such as oil and gas drilling, pipeline installation and mining. Innovations in the offering of tearout-proof technology for hydraulic

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Medication Market Size And Global Industry Forecast 2034
"As of 2024, the global ankylosing spondylitis (AS) medication market is valued at approximately $5 billion, driven by an increasing prevalence of the condition and a growing awareness of treatment options. The market is projected to reach roughly $9 billion by 2034, reflecting a robust growth trajectory over the next decade. The anticipated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at around
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate? The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638 Introduction: The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively. Unveiling Ankylosing
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/ Retail Pharmacy to Dominate the
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027. Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631 Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen